Procurement Summary
Country : USA
Summary : Primers and Probes
Deadline : 20 Jun 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 102307427
Document Ref. No. : VEID240021_1301162633
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Primers and probes designed to be used in the molecular diagnosis of Dengue virus (four serotypes), Chikungunya virus, Zika virus, Orthobunyavirus (including Guaroa, Oropouche, Group C, Bunyamwera and California viruses), Influenza virus (Influenza A-matrix gene and B) and its subtypes (H3, H1pdm/SwH1N1, H1 seasonal), and SARS-CoV-2. Primers and probes will be used in reverse transcription (RT) real-time PCR assays using serum samples from febrile surveillance protocol and nasopharyngeal swab samples from the respiratory surveillance protocol. The items have all been validated and are compatible with the equipment in use at NAMRU SOUTH: 7500 Fast Real-Time PCR and QuantStudio platforms.
INFA-FSC2-F1-100 Influenza A Multiplex Fwd Primer 1, 100 nmol - 2 quatities INFA-FSC2-F2-100 Influenza A Multiplex Fwd Primer 2, 100 nmol - 2 quantities INFA-FSC2-R1-100 Influenza A Multiplex Rev Primer 1, 100 nmol - 3 quantities INFA-FSC2-R2-100 Influenza A Multiplex Rev Primer 2, 100 nmol - 1 quantity INFA-FSC2-P-25 Influenza A Multiplex Probe, 25 nmol - 4 quantities INFB-FSC2-F-100 Influenza B Multiplex Fwd Primer, 100 nmol - 4 quantities INFB-FSC2-R-100 Influenza B Multiplex Rev Primer, 100 nmol - 4 quantities INFB-FSC2-P-25 Influenza B Multiplex Probe, 25 nmol - 4 quantities SC2-FSC2-F-100 SARS-CoV-2 Multiplex Fwd Primer, 100 nmol - 4 quantities SC2-FSC2-R-100 SARS-CoV-2 Multiplex Rev Primer, 100 nmol - 4 quantities SC2-FSC2-P-25 SARS-CoV-2 Multiplex Probe, 25 nmol - 4 quantities RNP-F-100 Human RNase P Extraction Control Forward Primer - 100 nmol - 4 quantities RNP-R-100 Human RNase P Extraction Control Reverse Primer - 100 nmol - 4 quantities RNP-FSC2-P-25 Human RNase P Multiplex Probe, 25 nmol - 4 quantities DLO-CAB2-2 Dual-labeled Probe, 5' CAL Fluor Red 610/3' BHQ -2 200 nmol - 7 quantities DLO-COB1-2 Dual-labeled Probe, 5' CAL Fluor® Orange 560/3' BHQ-1 200 nmol - 5 quantities DLO-FB1-2 Dual-labeled Probe, 5' FAM/3' BHQ-1 200 nmol - 33 quantities DLO-F...
Active Contract Opportunity Notice ID VEID240021_1301162633 Related Notice Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEPT OF THE NAVY Major Command NAVSUP Sub Command NAVSUP OTHER HCA Sub Command 2 BUMED Sub Command 3 NAVY MEDICINE WEST Office NAVAL MEDICAL RESEARCH CENTER
General Information
Contract Opportunity Type: Solicitation (Original)
All Dates/Times are: (UTC-05:00) LIMA, PERU
Original Published Date: Jun 06, 2024 03:12 pm UTC-05
Original Date Offers Due: Jun 20, 2024 12:00 am UTC-05
Inactive Policy: 15 days after date offers due
Original Inactive Date: Jul 05, 2024
Initiative: None
Classification
Original Set Aside: 8(a) Sole Source (FAR 19.8)
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 423450 - Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Place of Performance: Bellavista, PE-LIM 01 PER
Documents
Tender Notice
VEID240021_SOW.docx